| Insight Eyecare, Inc. | |
|
205 House Carlson Dr, Batesville, MS 38606-7643 | |
| (662) 561-1234 | |
| (662) 729-4510 |
| Full Name | Insight Eyecare, Inc. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 205 House Carlson Dr, Batesville, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285070524 | NPI | - | NPPES |
| 03734792 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 649 (Mississippi) | Primary |
| Provider Name | Michael S Hellums |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1083659684 PECOS PAC ID: 6507869294 Enrollment ID: I20060818000328 |
News Archive
Competitive Technologies, Inc. announced today the publication of the detailed results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTTC's Calmare® Pain Therapy Treatment
Cascade Technologies, Inc., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will receive NIH research funding through a collaboration with Omega Optical of Brattleboro, Vermont. This effort will accelerate development of a new class of medical endoscopes enhanced with proprietary multispectral imaging technology. The principal investigators on the project are Dr. Gary Carver, Director of Research at Omega Optical, and Dr. Daniel L. Farkas, Chairman and CEO of SMI.
Bladder cancer will kill upward of 170,000 people worldwide this year, but bladder cancer isn't fatal in the bladder. Instead, in order to be fatal the disease must metastasize to faraway sites. The question has been this: does localized, non-muscle invasive bladder cancer eventually become the more dangerous, muscle-invasive form of the disease, or are NMI and MI bladder cancers genetically distinct from the start?
Congressman and Majority Whip Kevin McCarthy, was honored by CHI-California Healthcare Institute with the organization's first-ever Leadership Award.
Hormonal treatment for breast cancer causes menopause in over 80% of women in the first year of therapy, but now new research, published in the peer-reviewed journal Climacteric, has found that how these women are diagnosed and treated for menopausal symptoms can vary substantially according to which type of doctor a woman sees.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Insight Eyecare, Inc. Po Box 557, Nesbit, MS 38651-0557 Ph: (662) 561-1234 | Insight Eyecare, Inc. 205 House Carlson Dr, Batesville, MS 38606-7643 Ph: (662) 561-1234 |
News Archive
Competitive Technologies, Inc. announced today the publication of the detailed results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTTC's Calmare® Pain Therapy Treatment
Cascade Technologies, Inc., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will receive NIH research funding through a collaboration with Omega Optical of Brattleboro, Vermont. This effort will accelerate development of a new class of medical endoscopes enhanced with proprietary multispectral imaging technology. The principal investigators on the project are Dr. Gary Carver, Director of Research at Omega Optical, and Dr. Daniel L. Farkas, Chairman and CEO of SMI.
Bladder cancer will kill upward of 170,000 people worldwide this year, but bladder cancer isn't fatal in the bladder. Instead, in order to be fatal the disease must metastasize to faraway sites. The question has been this: does localized, non-muscle invasive bladder cancer eventually become the more dangerous, muscle-invasive form of the disease, or are NMI and MI bladder cancers genetically distinct from the start?
Congressman and Majority Whip Kevin McCarthy, was honored by CHI-California Healthcare Institute with the organization's first-ever Leadership Award.
Hormonal treatment for breast cancer causes menopause in over 80% of women in the first year of therapy, but now new research, published in the peer-reviewed journal Climacteric, has found that how these women are diagnosed and treated for menopausal symptoms can vary substantially according to which type of doctor a woman sees.
› Verified 7 days ago
Dr. Benjamin T Hubbard Jr., OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 260 Power Dr, Batesville, MS 38606 Phone: 662-563-5533 Fax: 662-563-0777 | |
Dr. Michael Shawn Hellums, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 205 House Carlson Dr, Batesville, MS 38606 Phone: 662-561-1234 Fax: 662-729-4510 | |
Batesville Vision Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 365 Highway 51 N, Batesville, MS 38606 Phone: 662-563-9880 Fax: 662-563-9882 | |
Dr. Sandra Lynn Bright, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 365 Highway 51 N, Batesville, MS 38606 Phone: 662-563-9880 Fax: 662-563-9882 | |
Tu Lam Stone, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 365 Highway 51 N, Batesville, MS 38606 Phone: 662-563-9880 | |
Dr. Charla Shea Darby, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 150 Cracker Barrel Dr., Batesville, MS 38606 Phone: 662-270-8090 |